The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience.
Hidaka M, Hara T, Soyama A, Sasaki R, Matsushima H, Tanaka T, Hamada T, Imamura H, Adachi T, Kanetaka K, Miyaaki H, Okano S, Eguchi S.
Hidaka M, et al. Among authors: okano s.
Anticancer Res. 2022 Jun;42(6):3049-3054. doi: 10.21873/anticanres.15791.
Anticancer Res. 2022.
PMID: 35641262